- This article examines whether McCormick, trading at around US$51.58, represents a bargain or a potential trap, and explores what the current price might indicate about value.
- The share price has moved sharply recently, with a 4.6% 7 day return, a 26.3% 30 day return and a 23.3% year to date return all in negative territory, and a 35.2% decline over the past year that stands out for long term holders.
- Recent coverage of consumer staples stocks has focused on how investors are reassessing pricing power, input cost pressures and the appeal of defensive names relative to other sectors. For McCormick, this discussion helps frame whether the recent 31.7% 3 year and 35.9% 5 year returns, both negative, reflect short term sentiment or a shift in how the business is being valued.
- Right now, McCormick scores a value check of 6 out of 6 based on six separate valuation checks. The next sections walk through traditional valuation methods and then finish with a more comprehensive way to think about what the stock might be worth.
Find out why McCormick's -35.2% return over the last year is lagging behind its peers.
Approach 1: McCormick Discounted Cash Flow (DCF) Analysis
A Discounted Cash Flow, or DCF, model estimates what a business could be worth by projecting its future cash flows and then discounting those back to today using a required return. It is essentially asking what all those future dollars are worth in present terms.
For McCormick, the model used is a 2 Stage Free Cash Flow to Equity approach, based on cash flow projections in $. The latest twelve month free cash flow sits at about $705 million. Analyst estimates extend to 2028, where free cash flow is projected at $1,136 million, and Simply Wall St then extrapolates cash flows out to 2035, with each of those future figures discounted back to today.
Aggregating these discounted cash flows gives an estimated intrinsic value of about $121.43 per share. Compared with a current share price around $51.58, the DCF suggests the stock trades at a 57.5% discount to this intrinsic estimate. On this model alone, McCormick appears significantly undervalued.
Result: UNDERVALUED
Our Discounted Cash Flow (DCF) analysis suggests McCormick is undervalued by 57.5%. Track this in your watchlist or portfolio, or discover 61 more high quality undervalued stocks.
Approach 2: McCormick Price vs Earnings
For a profitable company, the P/E ratio is a useful shorthand for how much investors are paying for each dollar of earnings. It is a practical way for you to compare McCormick with other food stocks. A higher P/E typically lines up with stronger expected growth or lower perceived risk, while a lower P/E can reflect more modest growth expectations or higher uncertainty.
McCormick currently trades on a P/E of 17.54x. That sits below the Food industry average of 20.71x and well below the peer group average of 38.51x, which suggests the market is applying a lower earnings multiple than many comparable companies. To refine that comparison, Simply Wall St uses a proprietary “Fair Ratio”, which indicates the P/E that might be expected given factors such as earnings growth, profit margins, industry, market cap and specific risks. For McCormick, this Fair Ratio is 19.55x.
Because the Fair Ratio is tailored to the company rather than a broad group, it can be more informative than simple peer or industry comparisons. With the current P/E of 17.54x sitting below the 19.55x Fair Ratio, the shares appear modestly undervalued on this earnings multiple view.
Result: UNDERVALUED
P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.
Upgrade Your Decision Making: Choose your McCormick Narrative
Earlier it was mentioned that there is an even better way to understand valuation. Narratives let you attach a clear story about McCormick to the numbers by linking your view of its future revenue, earnings and margins to a financial forecast. This turns that into a Fair Value you can easily compare with the current share price on Simply Wall St's Community page, where Narratives refresh automatically when news or earnings arrive. One investor might plug in a confident view built around health focused product launches, global partnerships and a Fair Value closer to the US$85 upper analyst target. Another might focus on input cost pressures, guidance resets and a Fair Value nearer the US$65 lower target. This gives you a structured way to decide whether the current price lines up with the story you believe.
Do you think there's more to the story for McCormick? Head over to our Community to see what others are saying!
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com